Perotti F, Landi G, Primatesta F, Colombo A, David P G, Castellaro E, Baraldi U
Divisione di Chirurgia Generale, USSL 54 Borgomanero, Novara.
Minerva Chir. 1992 Jun 30;47(12):1091-3.
The Authors report their experience of 121 patients who had undergone an elective abdominal operation and who had been previously considered under an immunological point of view and classified as anergic. The Authors have found a notable reduction of postoperative infection incidence in the 61 anergic operated patients who have been treated with Thymostimulin; they conclude by underlining the importance of careful consideration and eventual correction of immunological alterations of the patients of the patients who must undergo an operation.
作者报告了121例接受择期腹部手术患者的经验,这些患者先前从免疫学角度进行了评估并被归类为无反应性。作者发现,在61例接受胸腺刺激素治疗的无反应性手术患者中,术后感染发生率显著降低;他们强调,对于必须接受手术的患者,仔细考虑并最终纠正其免疫改变非常重要。